Sana Biotechnology, Inc.
(NASDAQ : SANA)

( )
SANA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.74%185.450.0%$900.62m
AMGNAmgen, Inc. -1.11%243.521.5%$585.46m
NVAXNovavax, Inc. 0.63%60.6575.7%$464.73m
VRTXVertex Pharmaceuticals, Inc. 1.19%291.471.9%$424.89m
GILDGilead Sciences, Inc. -0.80%60.601.0%$369.30m
REGNRegeneron Pharmaceuticals, Inc. 0.14%614.442.6%$344.92m
SNSSSunesis Pharmaceuticals, Inc. 0.00%3.870.7%$270.53m
ILMNIllumina, Inc. 1.05%226.123.3%$244.07m
BIIBBiogen, Inc. -0.84%216.361.8%$199.53m
GOVXGeoVax Labs, Inc. 2.48%3.300.0%$164.40m
BNTXBioNTech SE -8.80%167.000.0%$139.82m
CRSPCRISPR Therapeutics AG -1.63%80.070.6%$130.60m
RYTMRhythm Pharmaceuticals, Inc. 7.56%21.770.0%$98.19m
MRTXMirati Therapeutics, Inc. 3.99%90.011.6%$97.25m
APDNApplied DNA Sciences, Inc. 3.26%6.029.0%$97.10m

Company Profile

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.